Cannabis for the treatment of amyotrophic lateral sclerosis: What is the patients’ view?

Overview of attention for article published in Revue Neurologique, July 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#22 of 1,055)
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 2 news outlets

twitter: 20 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 16 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 24 X posts from 20 X users, with an upper bound of 36,304 followers.

@LifeSciHelsinki @helsinkiuni @MerjaVoutilain5 https://t.co/UmiNbs7L2d

23 Sep 2023

Reply Repost Favourite

”Participants mostly reported the use of cannabidiol (CBD) oil and cannabis weed and declared benefits both on motor (rigidity, cramps, fasciculations) and non-motor (sleep quality, pain, emotional state, quality of life, depression) symptoms…” https://t.c

23 Sep 2023

Reply Repost Favourite

Cannabis pour le traitement de la sclérose latérale amyotrophique : quel est l'avis des patients ? Cannabis for the treatment of amyotrophic lateral sclerosis: What is t... https://t.co/gWpStQBtRs

12 Aug 2023

Reply Repost Favourite

RT @fundacioncanna: #Cannabis for the treatment of amyotrophic lateral #sclerosis #ALS: What is the patients’ view? https://t.co/OyGQlDmXl7

06 Aug 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 20 additional X posts.